Cite

HARVARD Citation

    Narayanan, A. et al. (2022). Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases. Biochemical Society transactions. pp. 151-165. [Online]. 
  
Back to record